Quisultazine

This classification denotes a histamine-2 receptor antagonist with the molecular formula C21H25N3O2S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 60J29WG4Q6 chemically known as 10h-phenothiazine-2-sulfonamide, 10-(1-azabicyclo(2.2.2)oct-3-yl)-n,n-dimethyl- but generally known as quisultazine, which bears US NIH Compound Identifier 68833. European Medicines Agency schedules Quisultazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10228MIG. The term QUISULTAZINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, no. 6, 1984, list 24. ). Most nations schedule quisultazine under HS 29350090 and SITC 51580. As of Q4 2014, QUISULTAZINE remains the US FDA Preferred Term for this commodity. Quisultazine bears US NLM identifiers UMLS ID C2825481 and NCI Concept Code C81157. SMILES: CN(C)S(=O)(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2C4CN5CCC4CC5.